Back to Results
First PageMeta Content
Serotonin-norepinephrine reuptake inhibitors / Amines / Fabre / Hemangioma / Propranolol / Milnacipran / Food and Drug Administration / Levomilnacipran / European Medicines Agency / Medicine / Chemistry / Pharmacology


Pierre Fabre obtains FDA Approval to market HemangeolTM for the Treatment of Infantile Hemangioma th
Add to Reading List

Document Date: 2014-03-20 09:14:55

Open Document

File Size: 52,64 KB

Share Result on Facebook

Company

Pierre Fabre US / Pierre Fabre Pharmaceuticals Inc. (USA) / Forest Laboratories / Pierre Fabre Dermo / SAS / Pierre Fabre Laboratories / Pierre Fabre Dermatologie Pierre Fabre Laboratories / Pierre Fabre Dermatologie / Pierre Fabre USA / /

Country

France / United States / /

Currency

EUR / /

/

Event

Business Partnership / FDA Phase / /

Facility

Bordeaux University Hospital / /

IndustryTerm

pharmaceutical form / oral care products / propranolol treatment protocols / pharmaceutical expertise / pharmaceutical / healthcare / pharmaceuticals / placebo / pharmaceutical forms / pharmaceutical market / natural health products / treatment protocol / pharmaceutical and clinical development / /

MedicalCondition

bronchitis / alopecia / benign tumor / infantile hemangiomas / inflammatory dermatitis / respiratory tract infections / hemangioma / target hemangioma / bradycardia / psoriasis / diarrhea / hypersensitivity / hypoglycemia / fungal infections / proliferative infantile hemangioma requiring systemic treatment / hypotension / asthma / congestive heart failure / infantile hemangioma requiring systemic therapy / bronchospasm / acne / airway obstruction / heart block / stroke / infantile hemangiomas Infantile hemangioma / fever / bronchiolitis / vomiting / heart failure / pheochromocytoma / dermatological disorders / cough / sleep disorders / common vascular benign tumor / /

MedicalTreatment

treatment protocols / treatment protocol / /

Organization

Food and Drug Administration / Committee for Medicinal Products for Human Use / Bordeaux University Hospital / European Medicines Agency / FDA / /

Person

Jean-Jacques Voisard / Saffré / Dermatologist / Christine Léauté-Labreze / Pierre Fabre Dermatologie / René Furterer / Eric Ducournau / Pierre Fabre / Bertrand Parmentier / /

/

Position

General Manager / CEO / leading producer / /

Product

Hemangeol / propranolol hydrochloride / /

Technology

treatment protocol / four propranolol treatment protocols / /

URL

www.infantilehemangioma.com / www.pierre-fabre.com / /

SocialTag